Publication – Parkinson's Disease

Kuldip D. Dave, Shehan De Silv, Niketa P. Sheth, Sylvie Ramboz, Melissa J. Beck, Changyu Quang, Robert C. Switzer III, Syed O. Ahmad, Susan M. Sunkin, Dan Walker, Xiaoxia Cui, Daniel A. Fisher, Aaron M. McCoy, Kevin Gamber, Xiaodong Ding, Matthew S. Goldberg, Stanley A. Benkovic, Meredith Haupt, Marco A.S. Baptista, Brian K. Fiske, Todd B. Sherer, Mark A. Frasier
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease., 2014 70, 190-203

Marcellino D, Suárez-Boomgaard D, Sánchez-Reina M.D, Aguirre J.A, Yoshitake T, Yoshitake S, Hagman B, Kehr J, Agnati L.F, Fuxe K, Rivera A.
On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. J Neural Transm 2010, 117, 681-687.

Galter D, Pernold K, Yoshitake T, Lindqvist E, Kehr J, Olson L.
MitoPark mice mirror the slow progression of key Parkinson disease symptoms and the L-DOPA response. Genes, Brain and Behavior 2010, 9, 173-181.

Herrera-Marschitz M, Bustamante D, Morales P, Goiny M.
Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins. Neurotox Res 2007, 11(3-4), 169-82.

Kehr J, Hu X.J, Goiny M, Scheller D.K.
Continuous delivery of rotigotine decreases extracellular dopamine suggesting continuous receptor stimulation. J Neural Transm 2007, 114, 1027-1031.

Kehr J, Hu X.J, Yoshitake T, Scheller D.
Determination of the dopamine agonist rotigotine in microdialysates from the rat brain by microbore column liquid chromatography with electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 845, 109-113.

Aguirre J.A, Kehr J, Yoshitake T, Liu F.L, Rivera A, Fernandez-Espinola S, Andbjer B, Leo G, Medhurst A.D, Agnati L.F, Fuxe K.
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP. Brain Res 2005, 1033, 216-20.

Tanganelli S, Sandager Nielsen K, Ferraro L, Antonelli T, Kehr J, Franco R, Ferre S, Agnati L.F, Fuxe K, Scheel-Kruger J.
Striatal plasticity at the network level. Focus on adenosine A(2A) and D(2) interactions in models of Parkinson's Disease. Parkinsonism Relat Disord 2004, 10, 273-80.

Bustamante D, Bustamante L, Segura-Aguilar J, Goiny M, Herrera-Marschitz M.
Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats. Neurotox Res. 2004 5(8):569-77


  • PsychoGenics
  • 215 College Road, Paramus, NJ 07652
  • Tel: (914) 406-8000
  • Fax: (914) 406-8090